Profile
Mr. Manuel Castellón Leal is a Founding Partner & Legal Advisor at Cross Road Biotech Inversiones Biotecnológicas SGEIC SA. Mr. Castellón Leal also served on the board at Traslational Cancer Drugs Pharma SL.
He received his undergraduate degree from Universidad Complutense de Madrid and a graduate degree from the Instituto de Empresa SL.
Manuel Castellón Leal active positions
| Companies | Position | Start |
|---|---|---|
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas (CRB Inverbio) invests in companies located in Europe, mainly in Spain. The firm targets companies operating in the fields of healthcare, life sciences and biotechnology. It provides financing for early stage capital requirements with investment size ranging between EUR 2 million and EUR 4 million. It acquires both minority and majority interests. | Private Equity Investor | 2000-12-31 |
Former positions of Manuel Castellón Leal
| Companies | Position | End |
|---|---|---|
Traslational Cancer Drugs Pharma SL
Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Discovers and develops therapeutic solutions for the treatment of cancer | Director/Board Member | - |
Training of Manuel Castellón Leal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Universidad Complutense de Madrid
Universidad Complutense de Madrid Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instituto de Empresa SL
Instituto de Empresa SL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas (CRB Inverbio) invests in companies located in Europe, mainly in Spain. The firm targets companies operating in the fields of healthcare, life sciences and biotechnology. It provides financing for early stage capital requirements with investment size ranging between EUR 2 million and EUR 4 million. It acquires both minority and majority interests. | Finance |
Traslational Cancer Drugs Pharma SL
Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Discovers and develops therapeutic solutions for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Manuel Castellón Leal
















